Red blood cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity

Abstract: Red blood cell (RBC) transfusion therapy in sickle cell disease (SCD) is used to treat and prevent disease complications by providing nonsickle erythrocytes that survive for weeks in circulation. The suppression of sickle hemoglobin between transfusion episodes is dependent on donor RBC su...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Marianne E. M. Yee, Patricia E. Zerra, Richard O. Francis, Kirk A. Easley, Christopher M. Lough, James W. McCoy, Zahra Naseh, Bhaveshkumar B. Delvadia, Ashishkumar K. Parikh, Hailly E. Butler, Sean R. Stowell, Clinton H. Joiner, Cassandra D. Josephson, John D. Roback, Ross M. Fasano
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2026-07-01
Serie:	Blood Advances
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2473952926003198
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!